INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,221,485 | -22.5% | 544,639 | 0.0% | 4.60% | +2.8% |
| Q2 2023 | $22,210,378 | +4.1% | 544,639 | -4.9% | 4.47% | -19.3% |
| Q1 2023 | $21,335,547 | +34.3% | 572,459 | +25.7% | 5.54% | +34.5% |
| Q4 2022 | $15,883,254 | -24.2% | 455,238 | +21.6% | 4.12% | -16.9% |
| Q3 2022 | $20,952,000 | +35.2% | 374,409 | +25.0% | 4.96% | +15.3% |
| Q2 2022 | $15,497,000 | +33.8% | 299,409 | +87.8% | 4.30% | +38.5% |
| Q1 2022 | $11,584,000 | -39.0% | 159,409 | -0.7% | 3.11% | -10.1% |
| Q4 2021 | $18,981,000 | -13.0% | 160,527 | -1.3% | 3.46% | +2.2% |
| Q3 2021 | $21,815,000 | +212.9% | 162,620 | +26.9% | 3.38% | +462.1% |
| Q4 2020 | $6,972,000 | – | 128,162 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |